Global Active Implantable Medical Devices Market Size, Share, Development, Growth and Demand Forecast to 2023

  • ID: 4340253
  • Report
  • Region: Global
  • 136 pages
  • P&S Market Research
1 of 4
Market Overview

Active implantable medical device refers to any active medical device which is intended to be totally or partially introduced, surgically or medically, into the human body or by medical intervention into a natural orifice, and which is intended to remain after the procedure. Based on the product type different active implantable medical device products include implantable cardioverter defibrillators, neurostimulators, implantable cardiac pacemakers, implantable hearing devices, ventricular assist devices, implantable heart monitors/insertable loop recorders. The global active implantable medical devices market is expected to witness considerable growth during 2017 - 2023.

Implantable cardioverter defibrillators, which includes transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, held largest share in the global active implantable medical devices market in 2016, due to the increasing prevalence of cardiovascular diseases and high compliance for technologically advanced products. Transvenous implantable cardioverter defibrillators, which include biventricular implantable cardioverter defibrillators, dual-chamber implantable cardioverter defibrillators and single-chamber implantable cardioverter defibrillators held larger share in the global active implantable cardioverter defibrillators market in 2016, as compared to subcutaneous implantable cardioverter defibrillators.

The neurostimulators market is expected to witness highest growth during forecast period. The demand for neurostimulators, especially deep brain stimulators is increasing significantly across the globe. The increasing prevalence of chronic pain, such as neuropathic pain, pain due to diabetes, arthritis pain and pain from injury is significantly increasing the demand for neurostimulators.

Market Dynamics

The global active implantable medical devices market is expected to witness a CAGR of 8.0% during 2017 - 2023, and is estimated to reach $28,878.6 million by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, increasing healthcare expenditures and rising research and development activities are the major factors driving the growth of the global active implantable medical devices market. High cost of implantable medical devices and unfavorable reimbursement policies are key challenge limiting adoption of active implantable medical devices solutions.

Opportunities

The healthcare industry in emerging economies has witnessed significant growth over the past few years. The healthcare market size in the emerging economies is still a fraction of that in developed countries such as the U.S. and Western European countries. However, the difference illustrates the strong growth potential of emerging economies especially in Asia-Pacific and Latin America. The massive unexplored active implantable medical devices market would create ample revenue generation opportunities for the active implantable medical devices manufacturers.

The fragmented healthcare industry and high operating margins in emerging economies make them attractive to investors when compared to developed economies. The countries such as China and India have large population base and the healthcare infrastructure in these countries is improving, thus illustrating immense healthcare market potential. Manufacturing medical devices products in the developing regions tend to decrease the overall cost of manufacturing, thus reducing the cost of the product without altering the quality. With the increasing income level and the increasing compliance for high quality implants, the demand for active implantable medical devices is expected to increase in these countries.

Growth Drivers

The demand for active implantable medical devices is increasing due to increasing prevalence of cardiovascular diseases and increasing incidences of neurological disorders. Cardiovascular disease is the leading cause of premature death around the world. Implantable cardioverter defibrillators and implantable cardiac pacemakers are the key medical devices used for the treatment of different cardiovascular conditions. High prevalence of cardiovascular diseases depicts increased demand for these devices. According to the World Health Organization WHO, globally, around 17.5 million people died due to cardiovascular diseases in 2012, while the number is expected to reach 23.3 million by 2030.

Neurological disorders are characterized by dysfunctioning of the nervous system. These conditions include Parkinson’s disease, Alzheimer’s disease, fecal incontinence, epilepsy and depression. According to Alzheimer’s Association, approximately 5.3 million people aged 65 years and older were reported to have Alzheimer’s disease in 2015 in the U.S. It further reported that these numbers are expected to reach 7.1 million in 2025 and about 13.8 million in 2050. According to the Parkinson’s Disease Foundation (PDF), approximately 7 million to 10 million people across the globe have Parkinson’s disease. Similarly, according to PDF approximately 60,000 new cases of Parkinson’s disease are reported each year in the U.S. High incidence of neurological disorders fuels the demand for neurostimulators, which further drives the global active implantable medical devices market.

Competitive Landscape

The global active implantable medical devices market is highly consolidated with three companies including Medtronic plc, Abbott Laboratories, and Boston Scientific Corporation accounting for the major share in the global active implantable medical devices market. Key players are focusing on product innovation, collaboration and partnership to increase their market share. In May 2016, Boston Scientific Corporation launched the Precision Montage MRI Spinal Cord Stimulator (SCS) System after receiving approval from the U.S. Food and Drug Administration. The Precision Montage System offers customized relief to patients with chronic pain, while also enabling safe access to full body magnetic resonance imaging (MRI) in a 1.5 Tesla environment.

Some of the other key players in the global active implantable medical devices market are BIOTRONIK SE & Co. KG, LivaNova PLC, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd., Sonova Holding AG, and MED-EL.

Scope for Customization

Customization is offered as per specific business requirements of clients. Illustrative customization within the scope of this report includes:
  • Period of Analysis - Increase in the study period, including historic and forecast years.
  • Geographical Analysis - Increase in country coverage.
  • Segment Analysis - More granular coverage related to:
  • Further analysis of different active implantable medical devices products in different country.
  • Company Profiles - Wider company coverage in terms of detailed analysis or additional company profiles.
  • New custom report - A completely customized report can be provided on the market, specific to a region/ country/ segment.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation By Product
1.3.2 Market Segmentation By Geography
1.3.3 Analysis Period
1.3.4 Market Data Reporting Unit
1.3.4.1 Value
1.4 Key Stakeholders

2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown Of Primary Research Respondents
2.2.1.1 By Region
2.2.1.2 By Industry Participants
2.2.1.3 By Company Type
2.3 Market Size Estimation
2.4 Market Breakdown And Data Triangulation
2.5 Assumptions For The Study

3. Executive Summary
3.1 Key Findings
3.2 Research Summary

4. Introduction
4.1 Market Segmentation
4.1.1 Overview By Product
4.1.1.1 Implantable Cardioverter Defibrillator (Icd)
4.1.1.1.1 Transvenous Icd (T-Icd)
4.1.1.1.1.1 Biventricular Icd
4.1.1.1.1.2 Dual Chamber Icd
4.1.1.1.1.3 Single Chamber Icd
4.1.1.1.2 Subcutaneous Icd (S-Icd)
4.1.1.2 Neurostimulator
4.1.1.2.1 Spinal Cord Stimulator (Scs)
4.1.1.2.2 Deep Brain Stimulator (Dbs)
4.1.1.2.3 Sacral Nerve Stimulator (Sns)
4.1.1.2.4 Vagus Nerve Stimulator (Vns)
4.1.1.2.5 Gastric Electrical Stimulator (Ges)
4.1.1.3 Implantable Cardiac Pacemaker (Icp)
4.1.1.4 Implantable Hearing Device (Ihd)
4.1.1.4.1 Active Hearing Implant
4.1.1.4.2 Passive Hearing Implant
4.1.1.5 Ventricular Assist Device (Vad)
4.1.1.6 Implantable Heart Monitor (Ihm)/ Insertable Loop Recorder (Ilr)
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Adoption Of Miniaturized Implants
4.2.1.2 Market Consolidation
4.2.1.3 Development Of Advanced Hearing Implants
4.2.2 Drivers
4.2.2.1 Increasing Prevalence Of Cardiovascular Diseases And Neurological Disorders
4.2.2.2 Technologically Advanced Active Implantable Devices
4.2.2.3 Increasing R&D Investments
4.2.2.4 Growing Aging Population
4.2.2.5 Impact Analysis Of Drivers On Market Forecast
4.2.3 Restraints
4.2.3.1 High Cost Of Active Implantable Devices And Lack Of Skilled Professionals
4.2.3.2 Risk Associated With Active Implantable Medical Devices
4.2.3.3 Unfavorable Healthcare Reforms In U.S.
4.2.3.4 Stringent Regulatory Requirements
4.2.3.5 Impact Analysis Of Restraints On Market Forecast
4.2.4 Opportunities
4.2.4.1 Growing Active Implantable Medical Device Market In Emerging Countries
4.2.4.2 Evolution Of S-Icd
4.3 Porter's Five Forces Analysis
4.3.1 Bargaining Power Of Buyers
4.3.2 Bargaining Power Of Suppliers
4.3.3 Threat Of New Entrants
4.3.4 Intensity Of Rivalry
4.3.5 Threat Of Substitutes

5. Market Size And Forecast By Product
5.1 Global Icd Market
5.1.1 Global Icd Market, By Type
5.1.1.1 Global T-Icd Market, By Type
5.1.2 Global Icd Market, By Region
5.2 Global Neurostimulator Market
5.2.1 Global Neurostimulator Market, By Type
5.2.2 Global Neurostimulator Market, By Region
5.3 Global Icp Market
5.3.1 Global Icp Market, By Region
5.4 Global Ihd Market
5.4.1 Global Ihd Market, By Type
5.4.2 Global Ihd Market, By Region
5.5 Global Vad Market
5.5.1 Global Vad Market, By Region
5.6 Global Ihm/Ilr Market
5.6.1 Global Ihm/Ilr Market, By Region

6. Market Size And Forecast By Geography
6.1 North America Active Implantable Medical Device Market
6.1.1 North America Active Implantable Medical Device Market, By Product
6.1.1.1 North America Icd Market, By Type
6.1.1.1.1 North America T-Icd Market, By Type
6.1.1.2 North America Neurostimulator Market, By Type
6.1.1.3 North America Ihd Market, By Type
6.1.2 North America Active Implantable Medical Device Market, By Country
6.2 Europe Active Implantable Medical Device Market
6.2.1 Europe Active Implantable Medical Device Market, By Product
6.2.1.1 Europe Icd Market, By Type
6.2.1.1.1 Europe T-Icd Market, By Type
6.2.1.2 Europe Neurostimulator Market, By Type
6.2.1.3 Europe Ihd Market, By Type
6.2.2 Europe Active Implantable Medical Device Market, By Country
6.3 Asia-Pacific Active Implantable Medical Device Market
6.3.1 Asia-Pacific Active Implantable Medical Device Market, By Product
6.3.1.1 Asia-Pacific Icd Market, By Type
6.3.1.1.1 Asia-Pacific T-Icd Market, By Type
6.3.1.2 Asia-Pacific Neurostimulator Market, By Type
6.3.1.3 Asia-Pacific Ihd Market, By Type
6.3.2 Asia-Pacific Active Implantable Medical Device Market, By Country
6.4 Latin America Active Implantable Medical Device Market
6.4.1 Latam Active Implantable Medical Device Market, By Product
6.4.1.1 Latam Icd Market, By Type
6.4.1.1.1 Latam T-Icd Market, By Type
6.4.1.2 Latam Neurostimulator Market, By Type
6.4.1.3 Latam Ihd Market, By Type
6.4.2 Latam Active Implantable Medical Device Market, By Country
6.5 Middle East & Africa (Mea) Active Implantable Medical Device Market
6.5.1 Mea Active Implantable Medical Device Market, By Product
6.5.1.1 Mea Icd Market, By Type
6.5.1.1.1 Mea T-Icd Market, By Type
6.5.1.2 Mea Neurostimulator Market, By Type
6.5.1.3 Mea Ihd Market, By Type

7. Competitive Landscape
7.1 Product Benchmarking Of Key Players In The Global Active Implantable Medical Device Market
7.2 Global Strategic Developments
7.2.1 Product Launch/Approval
7.2.2 Merger And Acquisition
7.2.3 Business Expansion

8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Business Overview
8.1.2 Product And Service Offerings
8.2 Medtronic Plc
8.2.1 Business Overview
8.2.2 Product And Service Offerings
8.3 Boston Scientific Corporation
8.3.1 Business Overview
8.3.2 Product And Service Offerings
8.4 Biotronik Se & Co. Kg
8.4.1 Business Overview
8.4.2 Product And Service Offerings
8.5 Livanova Plc
8.5.1 Business Overview
8.5.2 Product And Service Offerings
8.6 William Demant Holding A/S
8.6.1 Business Overview
8.6.2 Product And Service Offerings
8.7 Sonova Holding Ag
8.7.1 Business Overview
8.7.2 Product And Service Offerings
8.8 Med-El
8.8.1 Business Overview
8.8.2 Product And Service Offerings
8.9 Cochlear Ltd.
8.9.1 Business Overview
8.9.2 Product And Service Offerings
8.1 Nurotron Biotechnology Co., Ltd.
8.10.1 Business Overview
8.10.2 Product And Service Offerings

9. Appendix
9.1 Abbreviations

List Of Tables
Table 1 Analysis Period Of The Study
Table 2 Global Active Implantable Medical Device Market Snapshot
Table 3 Drivers For The Market: Impact Analysis
Table 4 Restraints For The Market: Impact Analysis
Table 5 Global Active Implantable Medical Device Market, By Product, $M (2013 - 2016)
Table 6 Global Active Implantable Medical Device Market, By Product, $M (2017 - 2023)
Table 7 Global Icd Market, By Type, $M (2013 - 2016)
Table 8 Global Icd Market, By Type, $M (2017 - 2023)
Table 9 Global T-Icd Market, By Type, $M (2013 - 2016)
Table 10 Global T-Icd Market, By Type, $M (2017 - 2023)
Table 11 Global Icd Market, By Region, $M (2013 - 2016)
Table 12 Global Icd Market, By Region, $M (2017 - 2023)
Table 13 Global Neurostimulator Market, By Type, $M (2013 - 2016)
Table 14 Global Neurostimulator Market, By Type, $M (2017 - 2023)
Table 15 Global Neurostimulator Market, By Region, $M (2013 - 2016)
Table 16 Global Neurostimulator Market, By Region, $M (2017 - 2023)
Table 17 Global Icp Market, By Region, $M (2013 - 2016)
Table 18 Global Icp Market, By Region, $M (2017 - 2023)
Table 19 Global Ihd Market, By Type, $M (2013 - 2016)
Table 20 Global Ihd Market, By Type, $M (2017 - 2023)
Table 21 Global Ihd Market, By Region, $M (2013 - 2016)
Table 22 Global Ihd Market, By Region, $M (2017 - 2023)
Table 23 Global Vad Market, By Region, $M (2013 - 2016)
Table 24 Global Vad Market, By Region, $M (2017 - 2023)
Table 25 Global Ihm/Ilr Market, By Region, $M (2013 - 2016)
Table 26 Global Ihm/Ilr Market, By Region, $M (2017 - 2023)
Table 27 North America Active Implantable Medical Device Market, By Product, $M (2013 - 2016)
Table 28 North America Active Implantable Medical Device Market, By Product, $M (2017 - 2023)
Table 29 North America Icd Market, By Type, $M (2013 - 2016)
Table 30 North America Icd Market, By Type, $M (2017 - 2023)
Table 31 North America T-Icd Market, By Type, $M (2013 - 2016)
Table 32 North America T-Icd Market, By Type, $M (2017 - 2023)
Table 33 North America Neurostimulator Market, By Type, $M (2013 - 2016)
Table 34 North America Neurostimulator Market, By Type, $M (2017 - 2023)
Table 35 North America Ihd Market, By Type, $M (2013 - 2016)
Table 36 North America Ihd Market, By Type, $M (2017 - 2023)
Table 37 North America Active Implantable Medical Device Market, By Country, $M (2013 - 2016)
Table 38 North America Active Implantable Medical Device Market, By Country, $M (2017 - 2023)
Table 39 Europe Active Implantable Medical Device Market, By Product, $M (2013 - 2016)
Table 40 Europe Active Implantable Medical Device Market, By Product, $M (2017 - 2023)
Table 41 Europe Icd Market, By Type, $M (2013 - 2016)
Table 42 Europe Icd Market, By Type, $M (2017 - 2023)
Table 43 Europe T-Icd Market, By Type, $M (2013 - 2016)
Table 44 Europe T-Icd Market, By Type, $M (2017 - 2023)
Table 45 Europe Neurostimulator Market, By Type, $M (2013 - 2016)
Table 46 Europe Neurostimulator Market, By Type, $M (2017 - 2023)
Table 47 Europe Ihd Market, By Type, $M (2013 - 2016)
Table 48 Europe Ihd Market, By Type, $M (2017 - 2023)
Table 49 Europe Active Implantable Medical Device Market, By Country, $M (2013 - 2016)
Table 50 Europe Active Implantable Medical Device Market, By Country, $M (2017 - 2023)
Table 51 Asia-Pacific Active Implantable Medical Device Market, By Product, $M (2013 - 2016)
Table 52 Asia-Pacific Active Implantable Medical Device Market, By Product, $M (2017 - 2023)
Table 53 Asia-Pacific Icd Market, By Type, $M (2013 - 2016)
Table 54 Asia-Pacific Icd Market, By Type, $M (2017 - 2023)
Table 55 Asia-Pacific T-Icd Market, By Type, $M (2013 - 2016)
Table 56 Asia-Pacific T-Icd Market, By Type, $M (2017 - 2023)
Table 57 Asia-Pacific Neurostimulator Market, By Type, $M (2013 - 2016)
Table 58 Asia-Pacific Neurostimulator Market, By Type, $M (2017 - 2023)
Table 59 Asia-Pacific Ihd Market, By Type, $M (2013 - 2016)
Table 60 Asia-Pacific Ihd Market, By Type, $M (2017 - 2023)
Table 61 Asia-Pacific Active Implantable Medical Device Market, By Country, $M (2013 - 2016)
Table 62 Asia-Pacific Active Implantable Medical Device Market, By Country, $M (2017 - 2023)
Table 63 Latam Active Implantable Medical Device Market, By Product, $M (2013 - 2016)
Table 64 Latam Active Implantable Medical Device Market, By Product, $M (2017 - 2023)
Table 65 Latam Icd Market, By Type, $M (2013 - 2016)
Table 66 Latam Icd Market, By Type, $M (2017 - 2023)
Table 67 Latam T-Icd Market, By Type, $M (2013 - 2016)
Table 68 Latam T-Icd Market, By Type, $M (2017 - 2023)
Table 69 Latam Neurostimulator Market, By Type, $M (2013 - 2016)
Table 70 Latam Neurostimulator Market, By Type, $M (2017 - 2023)
Table 71 Latam Ihd Market, By Type, $M (2013 - 2016)
Table 72 Latam Ihd Market, By Type, $M (2017 - 2023)
Table 73 Latam Active Implantable Medical Device Market, By Country, $M (2013 - 2016)
Table 74 Latam Active Implantable Medical Device Market, By Country, $M (2017 - 2023)
Table 75 Mea Active Implantable Medical Device Market, By Product, $M (2013 - 2016)
Table 76 Mea Active Implantable Medical Device Market, By Product, $M (2017 - 2023)
Table 77 Mea Icd Market, By Type, $M (2013 - 2016)
Table 78 Mea Icd Market, By Type, $M (2017 - 2023)
Table 79 Mea T-Icd Market, By Type, $M (2013 - 2016)
Table 80 Mea T-Icd Market, By Type, $M (2017 - 2023)
Table 81 Mea Neurostimulator Market, By Type, $M (2013 - 2016)
Table 82 Mea Neurostimulator Market, By Type, $M (2017 - 2023)
Table 83 Mea Ihd Market, By Type, $M (2013 - 2016)
Table 84 Mea Ihd Market, By Type, $M (2017 - 2023)
Table 85 Abbott Laboratories - At A Glance
Table 86 Medtronic Plc - At A Glance
Table 87 Boston Scientific Corporation- At A Glance
Table 88 Biotronik Se & Co. Kg - At A Glance
Table 89 Livanova Plc - At A Glance
Table 90 William Demant Holding A/S - At A Glance
Table 91 Sonova Holding Ag- At A Glance
Table 92 Med-El - At A Glance
Table 93 Cochlear Ltd - At A Glance
Table 94 Nurotron Biotechnologyco., Ltd. - At A Glance

List Of Figures
Fig 1 Research Scope For The Global Active Implantable Medical Device Market
Fig 2 Research Methodology For The Global Active Implantable Medical Device Market
Fig 3 Regional Split Of Primary And Secondary Research
Fig 4 Breakdown Of Primary Research By Region
Fig 5 Breakdown Of Primary Research By Industry Participant
Fig 6 Breakdown Of Primary Research By Company Type
Fig 7 Data Triangulation Approach For The Global Active Implantable Medical Device Market
Fig 8 Aging Population As A Percentage Of Total Population
Fig 9 Porter's Five Forces Analysis Of The Global Active Implantable Medical Device Market
Fig 10 Global Active Implantable Medical Device Market, Snapshot (2016)
Fig 11 Global Active Implantable Medical Device Market, By Product, $M (2013 - 2023)
Fig 12 Global Icd Market, By Type, $M (2013 - 2023)
Fig 13 Global T-Icd Market, By Type, $M (2013 - 2023)
Fig 14 Global Icd Market, By Region, $M (2013 - 2023)
Fig 15 Global Neurostimulator Market By Type, $M (2013 - 2023)
Fig 16 Global Neurostimulator Market, By Region, $M (2013 - 2023)
Fig 17 Global Icp Market, By Region, $M (2013 - 2023)
Fig 18 Global Ihd Market, By Type, $M (2013 - 2023)
Fig 19 Global Ihd Market, By Region, $M (2013 - 2023)
Fig 20 Global Vad Market, By Region, $M (2013 - 2023)
Fig 21 Global Ihm/Ilr Market, By Region, $M (2013 - 2023)
Fig 22 Worldwide Major Markets For Active Implantable Medical Devices
Fig 23 North America Active Implantable Medical Device Market Snapshot
Fig 24 Europe Active Implantable Medical Device Market Snapshot
Fig 25 Asia-Pacific Active Implantable Medical Device Market Snapshot
Fig 26 Latin America Active Implantable Medical Device Market Snapshot
Fig 27 Mea Active Implantable Medical Device Market Snapshot
Fig 28 Product Benchmarking Of Key Players In The Global Active Implantable Medical Device
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll